Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees
Karina Oganezova(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Jon A Gothing(Brigham and Women's Hospital), Stephen R. Walsh(Beth Israel Deaconess Medical Center), Ludo Lavreys(Janssen (Belgium)), Janine Maenza(Fred Hutch Cancer Center), Alisha Pandit(Brigham and Women's Hospital), Nicole Espy(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Katherine E. Yanosick(Herzog Hospital), Elvin J Fontana-Martinez(Brigham and Women's Hospital), Robert W. Coombs(University of Namur), Erin A. Goecker, Michael S. Seaman(Beth Israel Deaconess Medical Center), Esther Kwara(Brigham and Women's Hospital), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Patricia D’Souza(National Institutes of Health), Raphael Dolin(Beth Israel Deaconess Medical Center), Joan Dragavon, Frank Tomaka(Janssen (United States)), Mary Allen(National Institutes of Health)
Cited by 2
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k